placeholder image
M. M. Milhem All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. 
    Lancet Oncology. 2018
    • Abstract
  • CT066 / 16 - Phase 1 study of MDM2 antagonist ASTX295 in patients with solid tumors with wild-type TP53 [abstract]
    2024
    • Contact
    full name
  • M. M. Milhem
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration